-
Mashup Score: 6
Not all cancer therapies are successful, but cancer researchers increasingly are able to identify the right treatments for the right patients at the right time. A researcher at the University of Oklahoma …
Source: medicalxpress.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 12A simple intervention benefits cancer patients while saving hospitals money, study shows - 2 month(s) ago
Cancer patients who received specialized mental health support as part of their treatment plan were more likely to see improvements in their quality of life and reductions in pain, depression and fatigue, …
Source: medicalxpress.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 9Benchmarking mismatch repair testing for patients with cancer receiving immunotherapy - 4 month(s) ago
Author links open overlay panel Elias Bou Farhat 1, Elio Adib 1, Melissa Daou 1, Abdul Rafeh Naqash 2, Ursula Matulonis 3, Kimmie Ng 3, David J. Kwiatkowski 1, Lynette M. Sholl 1, Amin H. Nassar 1 4 Mismatch repair deficiency (MMR-D) has become a theragnostic marker to guide treatment with immune checkpoint inhibitors (ICIs) for patients at all stages of cancer and with a growing number of tumor types. 1 The National Comprehensive Cancer Network (NCCN) recommends universal testing for mismatch repair
Source: www.sciencedirect.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0
An abstract is unavailable.
Source: journals.lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3
Summary:. By shedding light on the cellular origins of circulating DNA (cirDNA), this research provides important insights into the mechanisms of cirDNA production in cancer. Contrary to expectations, the increased cirDNA in patients with cancer was not derived predominantly from neoplastic cells or surrounding nonneoplastic epithelial cells; rather, the excess cirDNA originated primarily from leukocytes, implying a systemic impact of cancer on cell turnover or DNA clearance.See related article by Mattox et al., p. 2166 (1).
Source: aacrjournals.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 11
Intraepithelial T lymphocytes in the colon are distinct, and TCF-1 acts to suppress their antitumor immunity.
Source: www.science.orgCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Complete molecular characterisation is feasible for cancer pts - 7 month(s) ago
In the MATCH-R study, comprehensive profiling included successful sequencing of DNA and of RNA, enabling detection of actionable genomic alterations
Source: dailyreporter.esmo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1article - 7 month(s) ago
NewsOncology Times45(8):p 17-18, April 20, 2023. | DOI: 10.1097/01.COT.0000932012.82499.42Next-Generation Cell TherapiesNext-Generation Cell TherapiesThe Friends of Cancer Research (Friends) held a webinar to update progress on its project aimed at accelerating the development of engineered cell therapies for cancer patients. Jeff Allen, PhD, President and CEO of Friends, said the organization…
Source: journals.lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
An abstract is unavailable.
Source: journals.lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Home | Cancer Patient Resource Center - 8 month(s) ago
This handout discusses potential benefits and risks of learning your test results online. You’ll find tips for managing your expectations and minimizing stress. During and after cancer treatment, a common greeting—How are you? —may stir unpleasant emotions or cause confusion about how to answer. This handout offers insights and tips on responding in ways that help you. The key message is this: In medical settings, answering candidly is essential to optimizing your care. You may experience treatment
Source: cancerpatientresourcecenter.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
Testing method could point thousands more ##cancerPatients to lifesaving treatment https://t.co/ToHTPRwFjr